Champions Oncology (CSBR) Treasury Shares (2011 - 2026)
Champions Oncology (CSBR) recorded quarterly Treasury Shares of $708000.0 in Q1 2026, little changed quarter-over-quarter from $708000.0 in Q4 2025, and little changed on a YoY basis from $708000.0 in Q1 2025.
Champions Oncology (CSBR) Treasury Shares (2011 - 2026) Analysis & Trends
Champions Oncology's Treasury Shares history runs 12 years deep, the most recent figure standing at $708000.0 for Q1 2026.
- In Q1 2026, Treasury Shares changed 0.0% year-over-year to $708000.0; the TTM figure through Jan 2026 stood at $708000.0 (changed 0.0% YoY), while the FY2025 annual figure was $708000.0, changed 0.0% from the prior year.
- Treasury Shares was $708000.0 for Q1 2026 at Champions Oncology, roughly flat from $708000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $120333.0 in Q1 2024 to a low of $4896.0 in Q4 2023.
- Historically, Treasury Shares has averaged $101479.3 across 4 years, with a median of $120333.0 in 2024.
- Biggest YoY gain for Treasury Shares was 856.76% in 2024; the steepest drop was 0.0% in 2024.
- A 4-year view of Treasury Shares shows it stood at $708000.0 in 2023, then changed by 0.0% to $708000.0 in 2024, then changed by 0.0% to $708000.0 in 2025, then changed by 0.0% to $708000.0 in 2026.
- The last three Treasury Shares figures came in at $708000.0 (Q1 2026), $708000.0 (Q4 2025), and $708000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Champions Oncology | 78.46 Mn | 71.46 Mn | 13.89 Mn | 120,333.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 120,333.00 |
| Jan 31, 2026 | 120,333.00 |
| Jan 31, 2026 | 708,000.00 |
| Jan 31, 2026 | 708,000.00 |
| Oct 31, 2025 | 708,000.00 |
| Oct 31, 2025 | 120,333.00 |
| Oct 31, 2025 | 120,333.00 |
| Oct 31, 2025 | 708,000.00 |
| Jul 31, 2025 | 120,333.00 |
| Jul 31, 2025 | 708,000.00 |
| Jul 31, 2025 | 708,000.00 |
| Jul 31, 2025 | 120,333.00 |
| Apr 30, 2025 | 708,000.00 |
| Apr 30, 2025 | 120,333.00 |
| Apr 30, 2025 | 120,333.00 |
| Apr 30, 2025 | 708,000.00 |
| Jan 31, 2025 | 708,000.00 |
| Jan 31, 2025 | 708,000.00 |
| Jan 31, 2025 | 120,333.00 |
| Jan 31, 2025 | 120,333.00 |